Loading company…
Pando Nutrition engineers cattle gut microbiomes using CRISPR, with a product aimed at better feed digestion and lower methane.
Founded in 2017 in San Francisco, US, Pando Nutrition, Inc. is a biotechnology firm that engineers cattle microbiomes using CRISPR technology. Its core product, MicroMethane, is designed to improve fiber digestion, with claims of up to 30% lower feed costs and 50% lower methane emissions. It sells to agricultural producers and livestock farmers on a B2B basis. In August 2019 it raised USD 440,000 in a Seed round. Douglas Manofsky is CEO, and the company was established by Craig Rouskey and Douglas Manofsky.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in